Jan Stenvang

Jan Stenvang

Associate Professor


  1. 2023
  2. Published

    The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells

    Høeberg, M., Noer, Julie Boertmann, Vistesen, M. V., Bartels, Annette Snejbjerg, Bech, E. M., Nygård, S. B., Lademann, U., Stenvang, Jan, Liu, S., Fuglsang, Anja Thoe, Brünner, N. & Moreira, José, 2023, In: Molecular Oncology. 17, 8, p. 1595-1612

    Research output: Contribution to journalJournal articlepeer-review

  3. 2022
  4. Published

    Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer

    Stenvang, Jan, Vestlev, P. M., Jensen, B. V. & Pfeiffer, P., 2022, In: Annals of Translational Medicine. 10, 21, 4 p., 1184.

    Research output: Contribution to journalEditorialpeer-review

  5. 2021
  6. Published

    A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer

    Huang, P., Li, F., Mo, Z., Geng, C., Wen, F., Zhang, C., Guo, J., Wu, S., Li, L., Brunner, N. & Stenvang, Jan, 2021, In: Frontiers in Oncology. 11, 14 p., 669270.

    Research output: Contribution to journalJournal articlepeer-review

  7. Published
  8. Published

    New use for old drugs: Epirubicin in colorectal cancer

    Tarpgaard, L. S., Qvortrup, C., Nielsen, S. L., Stenvang, Jan, Detlefsen, S., Brunner, N. & Pfeiffer, P., 2021, In: Acta Oncologica. 60, 7, p. 954-956 3 p.

    Research output: Contribution to journalLetterpeer-review

  9. Published

    Reversal of ABCG2/BCRP-mediated multidrug resistance by 5,3’,5’-trihydroxy-3,6,7,4’-tetramethoxyflavone isolated from the Australian desert plant Eremophila galeata Chinnock

    Petersen, M. J., Lund, X. L., Semple, S. J., Buirchell, B., Franzyk, Henrik, Gajhede, Michael, Kongstad, Kenneth Thermann, Stenvang, Jan & Stærk, Dan, 2021, In: Biomolecules. 11, 10, 19 p., 1534.

    Research output: Contribution to journalJournal articlepeer-review

  10. Published

    Synthesis of thiazole linked chalcones and their pyrimidine analogues as anticancer agents

    Kesari, C., Rama, K. R., Sedighi, K., Stenvang, Jan, Björkling, Fredrik, Kankala, S. & Thota, N., 2021, In: Synthetic Communications. 51, 9, p. 1406-1416 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  11. 2020
  12. Published

    Targeting anti-cancer drug resistance in gastro-intestinal cancer: Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump

    Ladekarl, M., Schou, J. H. V., Roest, N. L., Stenvang, Jan, Brunner, N. & Vestlev, P. M., Sep 2020, p. S503-S504. 2 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearch

  13. Published

    The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP

    Ambjørner, S. E. B., Wiese, M., Köhler, S. C., Svindt, J., Lund, X. L., Gajhede, Michael, Saaby, Lasse, Larsen, Birger Brodin, Rump, S., Weigt, H., Brünner, N. & Stenvang, Jan, 4 Mar 2020, In: Cells. 9, 3, 22 p., 613.

    Research output: Contribution to journalJournal articlepeer-review

  14. Published

    ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer

    Palshof, J. A., Cederbye, C. N., Hgdall, E. V. S., Poulsen, T. S., Linnemann, D., Nygaard, S. B., Stenvang, Jan, Christensen, I. J., Jensen, B. V., Pfeiffer, P., Brunner, N., Yilmaz, M., Viuff, B. M. & Nielsen, Dorte Lisbet, 2020, In: International Journal of Molecular Sciences. 21, 14, 13 p., 5027.

    Research output: Contribution to journalJournal articlepeer-review

Previous 1 2 3 4 5 6 7 8 9 Next

ID: 12922